Chugai Pharmaceutic-Unsp ADRCHGCY
13F holders, Q4 2025 (December 31)13holders +5
4new positions
0sold out
$26.28avg. 13F price*
At the end of Q4 2025, 13 institutions reported holding Chugai Pharmaceutic-Unsp ADR (CHGCY) in their 13F filings, up 5 from Q3 2025. 4 opened new positions and 0 sold out. The largest holders were Confluence Investment Management LLC ($1.2M), Rhumbline Advisers ($1.2M) and Sterling Capital Management LLC ($1.2M).
- Company
- Chugai Pharmaceutic-Unsp ADR
- CUSIP
- 171269103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $248K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 30,169 shares bought and 3,196 shares sold, net +26,973 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Confluence Investment Management LLC | 0.02% | Add +4.6% | 45,369 | $1.2M |
| Rhumbline Advisers | 0.00% | Add +60.3% | 44,380 | $1.2M |
| Sterling Capital Management LLC | 0.02% | Reduce -6.7% | 44,024 | $1.2M |
| GAMMA Investing LLC | 0.02% | Add +18.4% | 12,645 | $332K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -0.5% | 10,551 | $277K |
| Riverbridge Partners LLC | 0.00% | New | 7,825 | $206K |
| Ancora Advisors LLC | 0.00% | New | 1,305 | $34K |
| Salomon & Ludwin, LLC | 0.00% | Add +20.0% | 577 | $16K |
| Hantz Financial Services, Inc. | 0.00% | No change | 297 | $8K |
| Thurston, Springer, Miller, Herd & Titak, Inc. | 0.00% | New | 256 | $7K |
| Accent Capital Management, LLC | 0.00% | No change | 200 | $5K |
| Signature Equity Partners, LLC | 0.00% | — | 63 | $2K |
| IMA Advisory Services, Inc. | 0.00% | New | 38 | $998 |
"% of holder's portfolio" is CHGCY's weight in each manager's 13F, not the share of Chugai Pharmaceutic-Unsp ADR the manager owns.